Rift Valley Fever Vaccine Development, Progress and Constraints. - Wikidata - awgldk - TriplyDB

Rift Valley Fever Vaccine Development, Progress and Constraints.

Rift Valley Fever Vaccine Development, Progress and Constraints.

http://www.wikidata.org/entity/Q42553036

about

Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence.Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths The One Health approach to identify knowledge, attitudes and practices that affect community involvement in the control of Rift Valley fever outbreaks Multi-criteria Decision Analysis to Model Ixodes ricinus Habitat Suitability.The Role of Hyalomma Truncatum on the Dynamics of Rift Valley Fever: Insights from a Mathematical Epidemic Model.Current Status of Rift Valley Fever Vaccine Development.Rift Valley fever: current challenges and future prospects

P2860

Q28066283-9078C53D-4497-4E24-9FDF-97EF34D2DC42 Q28469517-5EFD5D2A-3C07-4528-9A3D-454916A31CF7 Q28652554-2864917A-708F-4BE7-AAED-7C7EF31E20D4 Q34059387-26CB0337-F7A5-43F9-88DE-7A9D27F69B1C Q35616459-C531C944-B0F3-436D-8581-21E88A30257E Q35902010-864A5793-CF6B-4A22-89CA-41D54619F8E3 Q35975309-79AFDDF1-3E4D-4823-84F4-B0DE03C4FF3A Q36283074-B1EAE9FA-2454-4AB8-8717-D1367E7DC044 Q38669142-86A15B18-6893-43CD-A3F6-C68FF986763D Q40093035-5E0768DB-3DBF-4374-A0E2-DE0AAA0B9384 Q41929716-480DDB17-E0DC-498A-94E8-B30E5C0292AE Q56917525-B593D75E-E232-4648-B788-ABFFC7181545

P2860

Rift Valley Fever Vaccine Development, Progress and Constraints.

http://www.wikidata.org/entity/Q42553036

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Rift Valley Fever Vaccine Development, Progress and Constraints.

@en

Rift Valley Fever Vaccine Development, Progress and Constraints.

@nl

type

label

Rift Valley Fever Vaccine Development, Progress and Constraints.

@en

Rift Valley Fever Vaccine Development, Progress and Constraints.

@nl

prefLabel

Rift Valley Fever Vaccine Development, Progress and Constraints.

@en

Rift Valley Fever Vaccine Development, Progress and Constraints.

@nl

P1433

Q42553036-A806E631-0E4F-416B-A5C4-534DDA73FC76

P1476

Q42553036-BABB478E-5655-4588-AAA9-A87B2BA445E2

P2093

Q42553036-1CB989D1-D19C-4044-91C0-CB3016EDB1A4

Q42553036-51BB92A8-FED0-4163-8EF6-C962DED90254

Q42553036-5FDF4031-AE80-47AF-985B-B7DE1D4D4EAC

Q42553036-659A579E-2C0E-4863-AD9A-09D07F32A889

Q42553036-67B6B123-8165-4C31-A9AF-6B4DA2362CFC

Q42553036-FA951C21-CF4A-49C1-A5FB-BF36EA0B9739

P2860

Q42553036-08444EDE-CB88-445A-93B5-74D4880AA04F

Q42553036-1121D743-0FA6-4711-9404-7B752F080B80

Q42553036-11DFF209-D96B-4F48-954F-A76DAF674AE9

Q42553036-23178CF3-5021-411A-86DF-369EF9C73A25

Q42553036-4B86E430-1A24-413F-9D13-A5AE3C4CE9E6

Q42553036-4FE99344-3AFD-43BC-9805-89A137CE54F0

Q42553036-69687D67-36CB-4058-8E71-5476FABC00AD

Q42553036-72B94B07-096A-459C-ADA0-F1A4B582DBCC

Q42553036-7723A0ED-CA7C-4755-9431-85A32E98537A

Q42553036-7C7BDF0E-1ABD-4D24-B93A-C6E5B112B401

P304

Q42553036-3ED6BD84-C1AA-49BB-954B-E81058161F23

P31

Q42553036-93DB28B3-E716-4513-BB2E-F38386FD7C62

P356

Q42553036-188896BB-232C-41DD-B110-E1795CE5E9B5

P433

Q42553036-6624E15C-FF91-43D8-A5C0-CB64D065AC1E

P478

Q42553036-37AB0649-A946-4972-83DE-25D8C7651DE5

P577

Q42553036-855FC711-07B0-4BC3-ABD9-1B55155B0F37

P698

Q42553036-D2C40C22-98C5-49E7-9D4F-9A78F7EFE8B8

P921

Q42553036-8D91590F-005F-43EC-AF4A-D7FC14F87310

P932

Q42553036-CC321E2D-850D-48F3-9800-71A9085A848E

P356

P1433

Emerging Infectious Diseases

P1476

Rift Valley Fever Vaccine Development, Progress and Constraints.

@en

P2093

Hermann Unger

http://www.w3.org/2001/XMLSchema#string

James Zingeser

http://www.w3.org/2001/XMLSchema#string

Jeroen Kortekaas

http://www.w3.org/2001/XMLSchema#string

Peter de Leeuw

http://www.w3.org/2001/XMLSchema#string

Rob J M Moormann

http://www.w3.org/2001/XMLSchema#string

Stephane de La Rocque

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge

Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine

Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine

Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.

Development of a RVFV ELISA that can distinguish infected from vaccinated animals.

Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs

Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus.

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.

P304

e1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1709.110506

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21888781

http://www.w3.org/2001/XMLSchema#string

P921

Rift Valley fever phlebovirus

P932

3322093

http://www.w3.org/2001/XMLSchema#string